Feb 27, 2020 / 03:30PM GMT
Operator
Good morning, everyone, and welcome to ANI's Fourth Quarter 2019 Earnings Call. (Operator Instructions)
Please note, this call may be recorded. It is now my pleasure to turn today's program over to Mr. Arthur Przybyl. Please go ahead, sir.
Arthur S. Przybyl - ANI Pharmaceuticals, Inc. - President, CEO & Director
Thank you, Laurie. Good morning, everyone, and welcome to ANI's earnings conference call for the full year and fourth quarter 2019. My name is Art Przybyl, I'm the CEO. Joining me today is Stephen Carey, our Chief Financial Officer.
Before we begin, I want to refer everyone to the forward-looking statements language in this morning's press release, and ask each of you to review it carefully as important context for this conference call.
Discussions will also include certain financial measures that were not prepared in accordance with generally accepted accounting principles. Reconciliation of those non-GAAP financial measures can be found in our earnings release dated today.
ANI reported full year 2019 net
Q4 2019 ANI Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot